IGBA Makes Access Pact With WHO

Promotes The Use Of Generics And Biosimilars

 
• By Dave Wallace

The WHO has taken an “important first step” towards increased collaboration with the generics and biosimilars industries through an agreement with the IGBA to promote access to medicines, including working towards a reduced trial burden for biosimilars and speeding up registration for both generics and biosimilars.

Pills_World_Map
The global agreement will promote access to generics and biosimilars • Source: Shutterstock

More from Generics

More from Products